Nanexa AB (publ) (STO:NANEXA)
10.42
-0.08 (-0.76%)
Nov 4, 2026, 5:29 PM CET
Nanexa AB Revenue
Nanexa AB had revenue of 6.16M SEK in the quarter ending June 30, 2026, a decrease of -61.69%. This brings the company's total for the last twelve months to 51.90M, up 12.55% year-over-year. In the year 2025, Nanexa AB had annual revenue of 63.44M with 34.14% growth. That makes Nanexa AB the 41,095th largest company in the world by revenue and 594th in Sweden.
Revenue (ttm)
51.90M
Revenue Growth
+12.55%
P/S Ratio
59.02
Revenue / Employee
1.99M
Employees
17
Market Cap
1.99B
Revenue by Geography
- North America 30.98M 85.7%
- Nordic Countries 5.17M 14.3%
Fiscal year ended Dec 31, 2025 See the full Nanexa AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.44M | 16.15M | 34.14% |
| Dec 31, 2024 | 47.29M | -12.20M | -20.50% |
| Dec 31, 2023 | 59.49M | 31.31M | 111.13% |
| Dec 31, 2022 | 28.18M | 10.02M | 55.15% |
| Dec 31, 2021 | 18.16M | -2.82M | -13.43% |
| Dec 31, 2020 | 20.98M | 12.25M | 140.30% |
| Dec 31, 2019 | 8.73M | 4.58M | 110.36% |
| Dec 31, 2018 | 4.15M | 895.19K | 27.50% |
| Dec 31, 2017 | 3.25M | 1.23M | 60.82% |
| Dec 31, 2016 | 2.02M | -189.15K | -8.55% |
| Dec 31, 2015 | 2.21M | - | - |
| Dec 31, 2014 | 0 | - | - |
| Apr 30, 2014 | 186.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioGaia AB | 1.65B |
| EQL Pharma AB | 432.35M |
| Enzymatica AB | 51.49M |
| Cinclus Pharma Holding AB | 35.18M |
| Moberg Pharma AB | 16.76M |
| Orexo AB | 12.50M |
| Enorama Pharma AB | 1.45M |
| Dicot Pharma AB | 200.00K |
Nanexa AB News
- 5 weeks ago - Novo Nordisk Licenses Nanexa's PharmaShell In Deal Worth Up To EUR 1.165 Bln - Nasdaq
- 2 months ago - Nanexa AB Quarterly report: Q2 2026 - Filings
- 6 months ago - Nanexa AB Quarterly report: Q1 2026 - Filings
- 8 months ago - Nanexa AB Annual report: Q4 2025 - Filings
- 8 months ago - Nanexa AB Quarterly report: Q4 2025 - Filings
- 12 months ago - Nanexa AB Quarterly report: Q3 2025 - Filings